definiens: . Generic Filing shall have thc mcaning given to that term in Section 7.5(d ) . 1.85 . Generic Product shall mean : ( a ) allY pharmaceutical product sold by a Third Party t'or usc in the Field ( other than a Product sold by [COMPANY] or ils Related Parties ) that contains as an active ingredient ( i ) a Compound or ( ii ) another compound ( hat contains the [ same principal molecular structural fcatures ( but not necessarily all of the ame tTlIctural features ) as a Compollnd ] * . For purposes of this Section 1.85, another compound will be considered to [ have the same principal mokclliar structural features as a om pound if the only differences in structure from th ompound ( x ) arc due to post - translationa l modifications or events or infidclity of tmnslatioll or transcripti n or ( y ) arc minor differences in amino acid sequence . or ( z ) are differences in glycosylation patlcrns or t rtiary structures from the Compound · or ( b ) ] * any pharmaceutical product ( other than a Product or [COMPANY] Product that is Developed or Commercialized by a Party pursuant to this Agreement ) that is included in Wl application made before a Regulatory Authority for marketing approval in the [COMPANY] Territory ( i ) a being a [, or as being ' · comparable . ' ess ntially similar to ' or " bioe Illivalcnt to ' a Productf ', or as having any other similar designation with respect to such Product as provided under Applicable raw, or ( ii ) ill which the applicant of sllch application ( r lies . or seeks to rely, in whole 01 ' in part n clinical data included in an application for Regulatory Approval ora Product ] *